2624-44-4 Etamsylate AKSci H820
 
 
Loading Please Wait...
  H820    AKSci Bulk Reagent
Etamsylate
, 99% (HPLC)
 



IDENTITY
CAS Number:2624-44-4
MDL Number:MFCD00867499
MF:C10H17NO5S
MW:263.31
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:99% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:132-135°C
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Water: Soluble
Application(s):Inhibits biosynthesis and action of those prostaglandins

REVIEW

 'Ethamsylate is a haemostatic drug believed to work by increasing capillary endothelial resistance and promoting platelet adhesion. It also inhibits biosynthesis and action of those prostaglandins which cause platelet disaggregation, vasodilation and increased capillary permeability. In addition to being a haemostatic agent, ethamsylate also promotes angioprotective and proaggregant action. It stimulates thrombopoiesis and their release from bone marrow. Haemostatic action is due to activation of thromboplastin formation on damaged sites of small blood vessels and decrease of PgI2 (Prostacyclin I2) synthesis. The precise mechanism of action of etamsylate is unknown.'

REFERENCES
[1]Schulte J, Osborne J, Benson JW, Cooke R, Drayton M, Murphy J, Rennie J, Speidel B. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F31-5.
[2] Elbourne D, Ayers S, Dellagrammaticas H, Johnson A, Leloup M, Lenoir-Piat S; EC Ethamsylate Trial Group. Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2001 May;84(3):F183-7.
[3] Kovács L, Falkay G. Etamsylate as inhibitor of prostaglandin biosynthesis in pregnant human myometrium in vitro. Experientia. 1981 Nov 15;37(11):1182-3.
[4] R Hunt Etamsylate for prevention of periventricular haemorrhage Arch Dis Child Fetal Neonatal Ed. 2005 January; 90(1): F3-F5.
[5] Garay RP, Chiavaroli C, Hannaert P. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. Am J Ther. 2006 May-Jun;13(3):236-47.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
None

Hazard Statements
None

Precautionary Statements
Notavailable


Current as of May 10, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Antihemorrhagics


PubChem
  @PubMed